Healthcare >> CEO Interviews >> May 22, 2001
PAUL LAIKIND is Chairman of the Board, President, and Chief Executive
Officer of Metabasis Therapeutics, Inc. Dr. Laikind was one of the two
Founders of Gensia, Inc., where he was responsible for establishing
major research and development corporate partnerships with leading US
and European companies including Marion Merrell Dow, Sandoz, Boehringer
Mannheim, Pfizer and Sankyo. Dr. Laikind served on the Board of Gensia
Sicor from its formation until 1997. Dr. Laikind was a co-Founder of the
gene therapy company, Viagene, Inc., which went public and then was
acquired by Chiron in 1995. Dr. Laikind received a PhD from the
University of California-San Diego and served as a research faculty
member at UCSD School of Medicine. Profile
Therapeutics and an overview?
Dr. Laikind: Metabasis is a privately held, product focused,
biopharmaceutical company developing
